269 related articles for article (PubMed ID: 16979013)
1. The effects of carbenoxolone on human myocardial conduction: a tool to investigate the role of gap junctional uncoupling in human arrhythmogenesis.
Kojodjojo P; Kanagaratnam P; Segal OR; Hussain W; Peters NS
J Am Coll Cardiol; 2006 Sep; 48(6):1242-9. PubMed ID: 16979013
[TBL] [Abstract][Full Text] [Related]
2. Conduction slowing by the gap junctional uncoupler carbenoxolone.
de Groot JR; Veenstra T; Verkerk AO; Wilders R; Smits JP; Wilms-Schopman FJ; Wiegerinck RF; Bourier J; Belterman CN; Coronel R; Verheijck EE
Cardiovasc Res; 2003 Nov; 60(2):288-97. PubMed ID: 14613858
[TBL] [Abstract][Full Text] [Related]
3. Relationship between gap-junctional conductance and conduction velocity in mammalian myocardium.
Dhillon PS; Gray R; Kojodjojo P; Jabr R; Chowdhury R; Fry CH; Peters NS
Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1208-14. PubMed ID: 24134868
[TBL] [Abstract][Full Text] [Related]
4. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
[TBL] [Abstract][Full Text] [Related]
5. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning.
Papp R; Gönczi M; Kovács M; Seprényi G; Végh A
Cardiovasc Res; 2007 Jun; 74(3):396-405. PubMed ID: 17362896
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological modulation of cardiac gap junctions to enhance cardiac conduction: evidence supporting a novel target for antiarrhythmic therapy.
Eloff BC; Gilat E; Wan X; Rosenbaum DS
Circulation; 2003 Dec; 108(25):3157-63. PubMed ID: 14656916
[TBL] [Abstract][Full Text] [Related]
7. Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling.
Pijnappels DA; Schalij MJ; van Tuyn J; Ypey DL; de Vries AA; van der Wall EE; van der Laarse A; Atsma DE
Cardiovasc Res; 2006 Nov; 72(2):282-91. PubMed ID: 16956599
[TBL] [Abstract][Full Text] [Related]
8. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure.
Wiegerinck RF; de Bakker JM; Opthof T; de Jonge N; Kirkels H; Wilms-Schopman FJ; Coronel R
Basic Res Cardiol; 2009 May; 104(3):321-32. PubMed ID: 19139945
[TBL] [Abstract][Full Text] [Related]
9. Acute ischemia-induced gap junctional uncoupling and arrhythmogenesis.
De Groot JR; Coronel R
Cardiovasc Res; 2004 May; 62(2):323-34. PubMed ID: 15094352
[TBL] [Abstract][Full Text] [Related]
10. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in human left and right atrial conduction.
Kojodjojo P; Kanagaratnam P; Markides V; Davies DW; Peters N
J Cardiovasc Electrophysiol; 2006 Feb; 17(2):120-7. PubMed ID: 16533247
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological abnormalities occur prior to the development of clinical episodes of atrial fibrillation: observations from human epicardial mapping.
Kanagaratnam P; Kojodjojo P; Peters NS
Pacing Clin Electrophysiol; 2008 Apr; 31(4):443-53. PubMed ID: 18373763
[TBL] [Abstract][Full Text] [Related]
13. Role of gap junctions in the propagation of the cardiac action potential.
Rohr S
Cardiovasc Res; 2004 May; 62(2):309-22. PubMed ID: 15094351
[TBL] [Abstract][Full Text] [Related]
14. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
[TBL] [Abstract][Full Text] [Related]
15. Effects of the gap junction uncoupler palmitoleic acid on the activation and repolarization wavefronts in isolated rabbit hearts.
Dhein S; Krüsemann K; Schaefer T
Br J Pharmacol; 1999 Dec; 128(7):1375-84. PubMed ID: 10602315
[TBL] [Abstract][Full Text] [Related]
16. Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study.
Postema PG; van Dessel PF; de Bakker JM; Dekker LR; Linnenbank AC; Hoogendijk MG; Coronel R; Tijssen JG; Wilde AA; Tan HL
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):379-86. PubMed ID: 19808433
[TBL] [Abstract][Full Text] [Related]
17. Ischemia-induced arrhythmia: the role of connexins, gap junctions, and attendant changes in impulse propagation.
Cascio WE; Yang H; Muller-Borer BJ; Johnson TA
J Electrocardiol; 2005 Oct; 38(4 Suppl):55-9. PubMed ID: 16226075
[TBL] [Abstract][Full Text] [Related]
18. Reducing the cyclic variations of ultrasonic integrated backscatters and myocardial electrical synchronism by reversibly blocking intercellular communications with heptanol.
Lin LC; Wu CC; Lin MS; Lin SF; Liu YB
Ultrasound Med Biol; 2009 Feb; 35(2):209-18. PubMed ID: 18977069
[TBL] [Abstract][Full Text] [Related]
19. Effects of atropine on atrial refractoriness and its dispersion in humans.
Michelucci A; Padeletti L; Fradella GA; Molina Lova R; Monizzi D; Giomi A; Fantini F
Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):254-8. PubMed ID: 6746148
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning protects against arrhythmogenesis through maintenance of both active as well as passive electrical properties in ischemic canine hearts.
Shome S; Lux RL; Punske BB; MacLeod RS
J Electrocardiol; 2007; 40(6 Suppl):S150-9. PubMed ID: 17993314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
